Browse Data and Analysis

This report described Burma’s current production, regulations and trade for genetically engineered products, as well as recent activities focused on agricultural biotechnology. Burma’s (also called Myanmar) National Biosafety Framework and Biosafety Guidelines have been pending approval by the Ministry of Agriculture since before the 2021 coup.

Colombia’s agricultural industry widely utilizes innovative biotechnologies, and its regulatory environment remains open genetically engineered (GE) derived commodities. However, congressional anti-biotechnology initiatives continue to risk undoing decades of scientific advancement, undermining biotechnology development and potentially impacting agricultural trade.

While Colombia´s regulatory environment remains friendly toward the adoption of biotechnology-derived crops and products, congressional anti-biotechnology initiatives pose a threat to further acceptance, and risk undermining future investments to benefit consumers and the agricultural sector.

This report describes the status of Burma’s production and regulations for genetically engineered products and recent activities focused on agricultural biotechnology.

While Colombia's regulatory environment remains friendly toward the adoption of biotech-derived commodities and other innovative technologies, Congressional anti-biotechnology initiatives continue posing a threat, risking the benefits to consumers and the agricultural sector. In 2021, genetically engineered corn area planted grew 31 percent, reaching record figures, and genetically engineered cotton area planted recovered 55 percent compared to 2020.

This report describes the status of Burma’s production, regulations, public attitudes, trading, and labeling requirements for genetic engineered products and the current activities for agricultural biotechnology.

Colombia remains open to biotechnology and other innovative technologies. In 2020, Colombia's GE corn acreage grew 23 percent while GE cotton acreage declined 37 percent.

Colombia remains open to the adoption of biotech-derived commodities and innovative technologies.

Although Burma (also called Myanmar) does not yet have a comprehensive biosafety legislation, the final version of the National Biosafety Framework is completed and pending approval...

On April 22, 2020, the Food and Surveillance Institute, INVIMA, issued communication IVC-INS-LI15 which establishes the frequency that importers must present laboratory results...

Colombia remains open to the adoption of biotech-derived commodities and innovative technologies.

There are no significant developments to convey since the previous report from November 2018.